NeoGenomics Inc (NEO) Stock Analysis

NeoGenomics Inc (NEO) is a publicly traded company in the HEALTHCARE sector. It trades at $10.12, carries a market capitalization of $1.36B. This page summarizes the public market data, fundamentals, and frequently asked questions for NEO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $10.12
• Market Cap: $1.36B
• EPS: $-0.77
• 52-Week High: $13.74
• 52-Week Low: $4.72

Market Sentiment

NeoGenomics Inc currently has a Bullish sentiment score of 0.26.

About NeoGenomics Inc

NeoGenomics, Inc. is a leading provider of cancer-focused diagnostics and testing services, with an extensive laboratory network across the United States, Europe, and Asia. Headquartered in Fort Myers, Florida, the company excels in advanced molecular and genomic testing solutions, empowering personalized treatment strategies that significantly improve patient outcomes. With a commitment to innovation and quality, NeoGenomics leverages cutting-edge technology and a wide range of diagnostic te...

GNG Research Analysis

GNG Research scores NeoGenomics Inc (NEO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NEO.

Frequently Asked Questions

Does NEO pay dividends?

NeoGenomics Inc (NEO) does not currently pay a regular dividend.

What is NEO's market cap?

NeoGenomics Inc (NEO) has a market capitalization of $1.36B with a current stock price of $10.12.